Bed Bath & Beyond Inc.
NYSE:BBBYSpecialty Retail
+$0.32 today
- Market cap
- $324.67M
- Beta
- 2.86
- P/E (TTM)
- -6.8
- EPS (TTM)
- -$0.88
Volume 1.33M
Average 3.06M
BBBY Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Bed Bath & Beyond Inc.NYSE: BBBY
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $21.21M fell 4.7% year over year, ahead of the -16.9% change in trailing-twelve-month research & development. Sequentially, it rose 28.6% from the prior quarter.
Context
- Research & development amounted to 8.6% of revenue in FY2025, up 1.7 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -4.7% holds above the trailing-twelve-month pace of -16.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 90.28M USD
- Year-over-year change
- -7.3%
- 4-year CAGR
- -4.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90.28M | -7.3% |
| FY2024 | 2024-12-31 | 97.43M | -5.2% |
| FY2023 | 2023-12-31 | 102.74M | -5.7% |
| FY2022 | 2023-02-25 | 108.93M | -0.3% |
| FY2021 | 2022-02-26 | 109.2M | — |
Research & Development vs competitors
How BBBY compares with its peers on the latest reported figures
- BBBY's LTM Mar 2026 research & development of $77.79M is the 2nd highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of -16.9% is the lowest of 2, against a peer median of +17.3%.
- Research & development amounts to 7.3% of revenue for BBBY, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $190.9M | +17.3% | -6.0% | 3.3% | |
| LTM Mar 2026 | $77.79M | -16.9% | — | 7.3% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BBBY) | $0 | +17.3% | -6.0% | 0.0% | |
Competitors are the stored peer set for BBBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Feb 2022 | FY2022 Feb 2023 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.76B | 1.93B | 1.56B | 1.39B | 1.04B |
| Cost of Revenue | 2.15B | 1.5B | 1.27B | 1.12B | 787.09M |
| Gross Profit | 606.04M | 427.37M | 295.84M | 272.55M | 257.52M |
| Gross Margin | 22.0% | 22.2% | 19.0% | 19.5% | 24.7% |
| Research & Development | 109.2M | 108.93M | 102.74M | 97.43M | 90.28M |
| Selling, General & Admin | 385.77M | 291.44M | 311.21M | 366.09M | 196.93M |
| Operating Expenses | 494.97M | 400.36M | 413.95M | 463.52M | 318.74M |
| Depreciation & Amortization | 23.49M | 21.96M | 19.45M | 19.06M | 16.28M |
| EBITDA | 147.06M | (11.89M) | (244.91M) | (236.85M) | (67.52M) |
| EBITDA Margin | 5.3% | -0.6% | -15.7% | -17.0% | -6.5% |
| Operating Income | 111.07M | 27.01M | (118.11M) | (190.97M) | (61.21M) |
| Operating Margin | 4.0% | 1.4% | -7.6% | -13.7% | -5.9% |
| Interest Income | 1.53M | 2.97M | 13.77M | 8.97M | 6.23M |
| Interest Expense | 2.08M | 0 | 1.76M | 2.2M | 1.17M |
| Other Income / Expenses | 11.94M | (60.86M) | (148.02M) | (67.14M) | (22.58M) |
| Income Before Tax | 123.02M | (33.85M) | (266.12M) | (258.11M) | (83.8M) |
| Pre-Tax Margin | 4.5% | -1.8% | -17.0% | -18.5% | -8.0% |
| Income Tax Expense | (48.78M) | 1.38M | 41.72M | 684K | 825K |
| Net Income | 108.55M | (35.24M) | (307.84M) | (258.8M) | (84.62M) |
| Net Margin | 3.9% | -1.8% | -19.7% | -18.6% | -8.1% |
| EPS (Basic) | 2.51 | (0.80) | (6.81) | (5.56) | (1.41) |
| EPS (Diluted) | 2.49 | (0.80) | (6.81) | (5.56) | (1.41) |
| Weighted Avg Shares | 42.98M | 44.32M | 45.21M | 46.54M | 60.13M |
| Weighted Avg Shares (Diluted) | 43.33M | 44.32M | 45.21M | 46.54M | 60.13M |
Bed Bath & Beyond Inc.
NYSE:BBBY
Intrinsic Alpha fair value
Locked
Current Price
$4.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.